Who is TLI?

Board of Directors

Click to read more.

Bill Oldham brings more than 25 years as an entrepreneur, investor, executive and consultant supporting growth industries and high value clients across health, technology, financial, and energy industries. 

Mr. Oldham has led many cutting edge and dynamic companies in a broad range of industries. From bringing fintech to the PBM space, to building two $100m companies from scratch, to managing global financial and health organizations – Mr. Oldham has led teams and projects bringing innovation and technical excellence across geography and industries. Mr. Oldham supports several startups with consulting and board level roles to drive business growth, develop strategy, and manage finance. 

Mr. Oldham’s career started on Wall Street working in the financial information services industry. Leading North and South American operations for a small technology company based in the UK, Mr. Oldham used technology to transform sales and service delivery, expand partnerships and networks and better support customers. Following this experience, Mr. Oldham has worked in financial, telecom, and healthcare industries including work in Europe, Africa and the Middle East. That experience, coupled with graduate education in the UK and Holland, has led to a belief system grounded in global experience.

Mr. Oldham then sought to combine his health and financial interests in the rapidly growing value based payments space bringing fintech to health.   In 2013, Mr. Oldham and a team of two other investors bought AscellaHealth, a long-term care focused pharmacy benefits manager with a strong technology foundation based outside Philadelphia.  With less than $1m in revenue in 2013, AscellaHealth has grown to manage over $300m in drug spend and more than $30m in revenue with strong profitability every year of operation.  A niche player focused on specialty pharma payments and rebate management, AscellaHealth is a leader in the value-based, transparency movement of PBMs.

In 2017, continuing to pursue fintech opportunities, Mr. Oldham founded CryptoCargo, a token-based, crypto currency solution. Mr. Oldham is a published author and speaker on cybersecurity, having led many projects across commercial and federal clients in security & cryptography applications, networks, and IT infrastructure. 

Mr. Oldham holds an BBA from Harding University with a major in Economics and a MBA in Entrepreneurship / Entrepreneurial Studies from Manchester Business School.

Shawn Murphy, Vice President of TLI, is an experienced leader and IT professional with an impressive history of driving organizational growth in both information technology and services industries. Her responsibilities as Vice President include developing, implementing and ensuring the integrity and effectiveness of the organizational core systems and administrative services that support TLI’s mission, vision and values.

Ms. Murphy’s work in commercial satellite communications, telecommunications, medical logistics and financial industries leveraged new technologies and project management best practices to re-engineer business processes and automate labor intensive and paper-heavy processes to transform business operations.

Her work for Defense Health Agency (DHA), Veterans’ Affairs (VA), and National Institutes of Health (NIH) programs focused on analysis of emerging technologies and enterprise-level business process transformation, interoperability, cybersecurity, and COTS integration

As a trustee of Aster DM Foundation, Alisha’s philanthropy and involvement in social welfare through Aster Volunteers program bridges the gap between people who would like to help with those in need. 

As a Young Global Leader elected by World Economic Forum in 2018, Alisha has a presence on the world leadership stage. Her other international accolades include 2018’s Top 100 World’s Greatest Leaders in Asia and GCC, one of Forbes Middle East magazine’s Top Next Generation Indian Leaders in 2018 and in 2021, inclusion in the list of Women of Influence in the Arab World by CEO Middle East magazine. Alisha joined the board of directors for the Thought Leadership & Innovation Foundation, a not-for-profit organization based in the United States working at the nexus of science, technology and public health in 2021. 

She is a Chartered Accountant from the ICAS (Institute of Chartered Accountants of Scotland) and worked with Ernst & Young.

Alisha graduated from the University of Michigan, Ann Arbor with distinction in Finance & Accounting and holds a degree in Global Leadership & Public Policy Change from Harvard University. 

Dr. Cecere served as the Chief Medical Officer of Evolvent (2012-2013). During his tenure with Evolvent, and during his previous tenure as the Chief Medical Officer for Expertech Solutions, he was a major force in the development of the Air Force Medical System (AFMS) Futures Group and in the transformation of that group into the Federal Health Futures Group (FHFG). During his three years as a coordinator of the FHFG, he demonstrated his acumen as a Futurist and as a highly skilled facilitator. As the current Chief Strategy Officer and Executive Director of the Thought Leadership & Innovation Foundation, he continues in a subject matter expert role to that organization. Until late 2008, Dr. Cecere was the Chief Medical Officer for Noblis (formerly Mitretek) a nationally prominent non-profit company working to improve healthcare performance in the Federal sector. Dr. Cecere has served as the President of the Society of Medical Consultants to the Armed Forces for the last two years.

Dr. Cecere has a passion for improving the quality of health care and planning for the delivery of health care. Throughout his career he has blended his clinical acumen, his experience leading provider organizations and his knowledge of systems to make a difference. He has performed pioneering work in outcomes research, led major process improvement projects within the National Quality Management Program of the Department of Defense, and has been instrumental in the design and early functional integration of both the National Capital Area Multi-Service Market and more recently the newly conceived Walter Reed National Military Medical Center.

In 2001, Dr. Cecere founded CFR Enterprises as a company dedicated to supporting and promoting businesses and biotech firms that seek to advance the principals of responsible and high-quality healthcare. During his 26-year military career he served as Special Staff officer to the Surgeon General (TSG)/Commander U.S. Army Medical Command (USAMEDCOM), the Deputy Surgeon General and the Assistant Surgeon General for Health Services, Financial Policy and Readiness Operations. Dr. Cecere assisted TSG in communicating his strategic vision to the Army Medical Department’s internal and external audiences.

Dr. Cecere received a Bachelor of Arts from Boston University College of Liberal Arts and received a Doctorate of Medicine from the Boston University School of Medicine.

TLI Fellows

TLI Fellows are all recognized innovators in their respective fields. Each Fellow works with TLI to pursue implementation of a common mission through either an active contract or a project in our Innovation Hub.

Click to read more.

Dr. A. Malathi joins TLI from Dubai, where she is the Chief Medical and Quality Officer of Aster DM Healthcare. She has deep experience in the field of healthcare focusing on quality programs. She holds a bachelor's degree in Medicine and Surgery from Bangalore University and a master’s degree in Human Physiology from Bombay University. She has also completed a training program in hospital administration from the Tata Institute of Social Sciences. Prior to joining Aster DM, she served at Fortis Hospitals Limited, Manipal Health Enterprises Private Limited and Lokmanya Tilak Municipal Medical College.

Mr. Bither is the current Managing Director of ForwardTrace, LLC where he helps clients develop advanced technology and data-driven strategies. He has served for 34 years in C-level, senior executive and operational leadership positions within the Federal and commercial space.  This includes Chief Technology Officer for a $700 million systems integrator, Vice President for Corporate Development for a technology startup, and Executive consultant to the Secretary of Defense for advanced technology.

Throughout his career, David has applied advanced technology to deliver solutions to his client’s most daunting problems.  He has leveraged Federal and private R&D investment to develop near-nano data systems to improve the performance of remote sensors, advanced cyber analytics to protect critical infrastructure, and award-winning data analytics that delivered actionable information in real-time.  In 2019, he was awarded intellectual property by the Federal government for his innovative development of AI-driven, Machine Leaning technologies.

David is a recognized expert in complex data analysis and, as such, was a by-name request by senior officials to create risk mitigation solutions for emerging cyber threats.  The suite of tools created was used to respond to the $3.6M Hollywood Presbyterian Medical Center cyber-attack.  This capability was also employed to mitigate and track cyber threats by the U.S. Department of the Treasury, a European central bank, and other critical infrastructure.  Current research includes the design of Deep Learning neural networks to accelerate decision making.

Mr. Bither is DAU certified in program management, systems engineering and acquisition.  He served as Chairmen of the International Consortium for data technology development.  David has been a senior advisor for technology and risk mitigation for the International Organization for Migration.  He received a Master’s Degree in Information Technology with a concentration in AI from George Washington University and a BA in Liberal Studies from Regents College, University of the State of New York.

Joseph Carabello has been involved in a broad range of developmental and operational activities relating to marketing communications throughout his career spanning healthcare, managed care, hospital marketing, medical travel, e-business and technology sectors. Holding key positions in several managed care organizations, as well as venture-based startups and consulting firms, Mr. Carabello has extensive experience in the healthcare industry. He has served on the board of numerous companies including managed care organizations, physician partnerships, and public service organizations. 

In addition, Mr. Carabello has acted as a consultant to the Office of Health Maintenance Organizations of the U.S. Department of Health and Human Services on marketing HMOs. He has served on the Board of Health Systems Agencies (HSAs) in New Jersey and Louisiana. A US Army Veteran, Carabello has served on several corporate and community boards, including Alvin Healthcare, Unotron LTD, Sphera Global Healthcare, The Bergen Community College Foundation, and The Molly Foundation for Juvenile Diabetes. Mr. Carabello recently initiated and funded Hannah’s Kitchen, a free food pantry for the underserved, located at a FQHC in a Northeast food desert.

Laura Carabello, founder and principal owner of CPR Strategic Marketing and Communications, has worked with over 1,000 companies, including public and private organizations, as a strategic consultant. She has been instrumental in the growth and development of multiple organizations both domestic and worldwide. She currently serves on the International Committee of the Self Insurance Institute of America and serves as special advisor to the American Macular Degeneration Foundation.

Recognized for innovation, Laura was on the founding team of Teladoc, the world’s leading telemedicine company. She has been invited by the US Federal Trade Commission to testify on healthcare advertising and marketing ethics and was recently tapped to develop special projects for Forbes magazine. She is the publisher and managing editor of Medical Travel and Digital Health News, the authoritative, online business-to business international newsletter of the medical tourism industry covering US domestic and international medical travel.

Pete serves as Chief Executive Officer of Healytics, a genetic data management platform and COO/EVP of CRE Technologies, leading the development of cyber solutions and products for the healthcare landscape. Pete has more than thirty-five years of experience in developing very complex technology solutions, across a wide spectrum of verticals including healthcare, media, manufacturing and cyber. He founded and led Performance Technology Group, an infrastructure engineering and outsourcing service provider focusing on the healthcare and intel markets. PTG, Inc. was sold to World Wide Technology in 2009 winning the prestigious Association of Corporate Growth’s Deal of the Year Award. 

Previously, Pete was a Senior Staff member at Johns Hopkins Bloomberg School of Public Health where he supported a variety of research studies including Migraine Headache, Prospective study of Central Nervous System Function in Amateur Boxers and the Human Genome.

Dr. Day joins TLI from the United Kingdom, expanding the Foundation’s global presence. His interests lie primarily in quantitative measurement, and he is driven to improve the quality of big, deep medical data by bringing engineering to the molecular sciences. His expertise in in nucleic acid measurement tools for quantitative integrative analyses of bio analytes, pathway function and mechanism analyses, microbiome and chronic inflammatory diseases, miniaturization for single cell studies and role of biological heterogeneity, systems biology and synthetic biology applications. 

Dr. Day is the  Principal Investigator in Synthetic Biology & Quantitative Genomics, Faculty of Biology, Medicine and Health Sciences, University of Manchester and Manchester Institute of Biotechnology (2007 to Present); Honorary Professor, Department of Medicine, University of Cape Town, South Africa (2021 to present); Honorary Professor, Bioengineering, Electrical Engineering & Computer Science, and Biophysics, UC Berkeley (2019 to present) and was Honorary Professor, Department of Biomedical Engineering, UC Irvine (2013 to 2018).

Dr. Marna E. Ericson currently serves as Assistant Professor, Department of Dermatology at the University of Minnesota. Dr. Ericson joined the University of Minnesota Department of Dermatology in 1996 as part of the Clinical Research Division team. She is Director of the research laboratory in Dermatology located in Diehl Hall and leads the Basic Science Friday resident lecture series.

Over the past 15 years, Dr. Ericson has adapted advanced imaging methodologies with new molecular techniques to improve understanding of vector-borne diseases with a long-term goal of deciphering the mechanisms and complex nature of co-infections. Her interests lie in imaging with special emphasis on single- and multi-photon laser scanning confocal microscopy. Her expertise in imaging has led to fruitful collaborations with other investigators outside the Department of Dermatology in the fields of infectious diseases, oncology, neuroscience, rheumatology, engineering, dentistry, and orthopedics.

Dr. Ericson has successfully administered collaborative projects with peer-reviewed publications as well as funding. With Innovation as a hallmark of her research endeavors, Professor Ericson has contributions like understanding and treating Cancer pain, identifying molecular targets of phytochemicals, comprehending the role of the peripheral nervous system in skin and hair biology, and recognizing the implications of Bartonellosis.

Dr. Ericson’s current research activities include cancer pain in a murine model, mechanisms of hair growth, tumor/T-cell interactions, mechanism of mammalian/tick infection, and second harmonic imaging of collagen.

Dr. Ericson became a Fellow of the Thought Leadership & Innovation Foundation (TLI) in 2018. She has contributed to Science with 47 peer-reviewed papers and has received several honors and awards in Imaging Science, including in 2013 as a Finalist in Posters/Graphics for the National Science Foundation (NSF) Science Engineering Visualization Challenge.

Ms. Foster is currently President of Fostering Innovation, LLC where she offers strategic consulting services to her clients. She retired from the Office of the Secretary of Defense in September 2014 after serving for 32 years in Comptroller and Health Affairs.

During her career she served in roles with increasing responsibility in the areas of Military Medicine and Programming and Budgeting. In Ms. Fosters’ most recent position with the Government, she served as the first Military Health System Chief Innovation Officer (CINO), directly reporting to the Assistant Secretary of Defense, Health Affairs. As the CINO, Ms. Foster spearheaded the activities of the MHS Innovation Strategy and team. Her main responsibilities included creating a sustaining culture of innovation across the Enterprise and supporting innovations in the areas of recapture of specialty and inpatient care, obesity and tobacco use reduction, and knowledge sharing.

From 2009-2011, Ms. Foster served as the Acting Deputy Assistant Secretary of Defense for Health Budgets and Financial Policy. In this role she was responsible for overseeing the Planning, Programming, Budgeting, and Execution (PPBE) process for the $50B Military Health System. During her tenure, she reengineered the PPBE process to ensure that key decisions were placed in the hands of senior leaders, a model which continues today.

Ms. Foster is Board Certified in Healthcare Management. She is a Fellow in the American College of Healthcare Executives and a Fellow at TLI. Ms. Foster has served on the Board of Trustees for the Metropolitan Area Prevention of Blindness Society since 2002. Ms. Foster has a Post Master’s Degree in Health Services Administration from George Washington University. She has an MA in Public Policy and Administration from Columbia University and a BA in Economics from the University of Texas, Austin.

Mr. Sam Hanna is the Associate Dean of Graduate and Professional Studies, an Executive in Residence and the Program Director of the master’s in healthcare management at American University in Washington, DC. He is an industry visionary and has developed a unique approach of bringing key industry best practices that represent the future direction of where the entire healthcare industry is headed. He is a sought-after advisor, mentor and speaker, and has provided consulting services to various organizations in the governments, industry, startup and the non-for-profit fields.

Prior to joining American University, Mr. Hanna was a professor and Program Director of the master’s Program in Management of Health Informatics & Analytics at The George Washington University where he created and directed the program to be a marquee program in the field. Prior to his academic career, he was the Chief Innovations Officer at PricewaterhouseCoopers LLP (PwC) and the Senior Director of the Health care practice in the Mid Atlantic.

Mr. Hanna also led the Health Reform program office tasked with determining the consulting firm’s response to policy changes impacting the healthcare field and clients. He also led the firm’s New Venture Incubator where he was responsible for creating strategic integrated solutions that brought multi-competency skills, tools and technologies to clients. In that capacity, he was responsible for designing, developing and enabling over $500M in new revenue and partnerships.

While he was leading these strategic initiatives, Mr. Hanna continued to serve clients to apply his knowledge and to remain focused on their needs. He is recognized nationally for his expertise in Project and Program Management, Business Intelligence and Analytics, Business Continuity, Complex Clinical & Financial Systems Implementations, HIPAA, ARRA/ HITECH, Audit, Risks and Governance Consulting, and the Convergence of the business of healthcare with IT. He has also held leadership opportunities at other organizations such as Deloitte and Dana Farber Cancer Institute.

Mr. Hanna is a PhD candidate in the field of Translational Health Sciences. He holds a graduate degree (MBA) from Babson College with a focus in Entrepreneurship and a dual degree from Christian Brothers University in Accounting and Information Technology Management. In addition, he holds a certificate of leadership and management from Harvard Business School. He also holds many certification and credentials including Six Sigma Green Belt Certification, Certified Information Systems Auditor (CISA), Certified Business Continuity Professional (CBCP), and Certified in Risk and Information Systems Controls (CRISC). He is active in the local chapters of the following organization:  ACHE, HIMSS, HFMA, DRII, The IIA and ISACA.

Rear Admiral (RADM) (Ret) Tom McGinnis has over 38 years of experience in the fields of military medicine, pharmacology and health care management. RADM (Ret) McGinnis served over 36 years in the United States Public Health Service and Department of Defense (DoD). At the time of his retirement in 2014, he served as Assistant Surgeon General and Chief of the Pharmaceutical Operations Directorate in the Office of the Assistant Secretary of Defense (Health Affairs) for the TRICARE Management Activity since 2005.

In this senior management position at the DoD, RADM (Ret) McGinnis was responsible for advising the Assistant Secretary on all pharmacy related matters and for executive leadership and technical directions for the management and operational implementation of the DoD $7 billion annual TRICARE pharmacy benefit program, which provides worldwide coverage for 9.5 million active duty and retired beneficiaries of the seven uniformed services and their families.

In this capacity, RADM (Ret) McGinnis directed and managed a staff of over 100 military and civilian employees. He also served as the Source Selection Authority for the TRICARE Pharmacy program acquisition contract, a $50 billion multi-year pharmacy benefit contract. The 2008 and 2014 awards were one of the few DoD contracts of this magnitude not appealed. In addition, he served as the Source Selection Authority for the TRICARE Managed Care South and West contract awards in 2012.

Prior to working at TRICARE, RADM (Ret) McGinnis served as Deputy Associate Commissioner for Health Affairs at the Food and Drug Administration. In addition, RADM (Ret) McGinnis deployed to Louisiana and served as Incident Commander for the Alexandria Special Needs Shelter, a 250-bed shelter staffed by over 100 health professionals, including active duty, inactive reserve, and federalized volunteers.

RADM (Ret) McGinnis is a recipient of the United States Surgeon General Medal and Distinguished Service Medal. He is a Life Member of AMSUS, the Military Officers Association and the PHS Commissioned Officers Association. He is also a Fellow of the American Pharmacists Association and gave the Commencement Address at the Rutgers College of Pharmacy in 2009. RADM (Ret) McGinnis is a Life Member of the United State Tennis Association and is a ranked singles and doubles player.

Dr. B. Robert Mozayeni is an expert in Translational Medicine, the science and art of advancing medical science safely and efficiently.

Dr. Mozayeni is a Rheumatologist with graduate and post-graduate physician-scientist training from Albany Medical College, Yale University, Howard Hughes Medical Institute, and the National Institutes of Health (NCI, NHLBI, and NIAMS). He is presently in private practice in Bethesda, MD where he specializes in chronic inflammatory diseases having rheumatic and neurovascular manifestations.

Dr. Mozayeni is the founder and Executive Director of the Translational Medicine Group where he has developed and commercialized software that supports data-driven methods to accelerate the evaluation and improvement of patient-centered care pathways. Under an ongoing research collaboration, Dr. Mozayeni maintains an observational clinical evaluation of the significance of Bartonella infection in a cohort of several hundred human patients with otherwise unexplained chronic conditions. Clinical correlations between Bartonella species and various conditions are being determined as part of ongoing research which continues to redefine diagnostic and therapeutic options as dictated by clinical experience.

Dr. Robin Robinson serves concurrently as a Fellow for Regenerative Medicine and Chronic Diseases at TLI, the acting Chief Executive Officer of Acquired Immune Medicines, Inc. developing new vaccines for influenza and other emerging pathogens, and an independent senior executive consultant for many pharmaceutical and biotechnology companies in the U.S. and Europe. He leads TLI’s development of cellular therapies to treat wounds from thermal, radiation, and diabetic wounds to establish a new regenerative medicine program.

He reentered the private pharmaceutical industry sector after retiring in 2016 from federal public service at the U.S. Department of Health and Human Services, where he served from 2008 - 2016 as the first director of the Biomedical Advanced Research and Development Authority (BARDA) and Deputy Assistant Secretary for Preparedness and Response. Dr. Robinson brought BARDA into prominence as one of the top 10 fully integrated R&D organizations worldwide supporting advanced development and acquisition of drugs, vaccines, diagnostics, and medical devices for man-made threats, pandemic influenza, and emerging infectious diseases. 38 of these medical countermeasure products supported by BARDA supported under his leadership were FDA approved. Under his leadership, BARDA established premier programs that developed treatments for acute radiation syndromes (ARS) with industry partners; novel cellular therapy technologies were utilized to treat ARS-associated neutropenia and thermal and radiation burns. In 2018, Dr. Robinson was recognized as one of top 100 innovators in medicine.

While at BARDA, Dr. Robinson served from 2004-2008 as the Director for the Influenza & Emerging Disease Division. Dr. Robinson established a program with scientific and technical experts to implement the national and global strategic plans and policies for the development of new influenza antiviral drugs, vaccines, and diagnostics outlined in the National Strategy for Pandemic Influenza. For his leadership in this role, Dr. Robinson was the recipient of the Department of Defense’s Clay Dalrymple Award in 2008, the HHS Distinguished Service Award three times, and a finalist for the Service to America Medal in 2009. From 2013- 2015, Dr. Robinson was recognized as one of the top 50 most influential persons worldwide in vaccines by Vaccine Nation.

Prior to public service, Dr. Robinson served as the Director of Vaccines at Novavax, Inc. (Rockville, MD) from 1995-2004, where he led the development of 20+ vaccines to hepatitis B and E, influenza, noroviruses, and human papilloma viruses from early development, clinical trials, manufacturing scale-up, and commercialization through FDA licensure. He developed patented platform vaccine technologies including virus-like particles and subunit protein vaccines for human pathogens including malaria, human papilloma, hepatitis, and influenza and for prostate, melanoma, and cervical cancers. Dr. Robinson pursued research from 1983-1992 on the molecular pathogenesis of herpesviruses and HIV while on faculty in the Department of Microbiology and Immunology at the University of Texas Southwestern Medical School.

Dr. Robinson received a Bachelor of Science degree from Millsaps College and a doctoral degree from the University of Mississippi Medical School in microbiology. He completed a NIH postdoctoral fellowship with the State University of New York at Stony Brook in molecular oncology.

Dr. Robinson also serves on the Senior Advisory Group for the World Health Organization (WHO) on emerging infectious diseases and pandemic influenza. Additionally, he continues to serve as an editorial board member and reviewer for several professional scientific and technical journals on virology, vaccines, public health, and biotechnology.

Mr. Emad Samad currently serves as the Managing Director of WBB Securities, an investment bank that focuses its practice in the life sciences. Since beginning his tenure at the firm, Mr. Samad has focused on advising immunotherapy, infectious disease, biodefense, gene and cell therapy, and regenerative medicine companies, and is the author of numerous publications on the subject of funding for biotechnology research in the United States. As a member of WBB’s senior banking team, Mr. Samad has worked extensively on private and public equity financings, working closely with the senior management of major biotechnology and medical device companies.

Mr. Samad has consulted numerous private and public companies on M&A transactions, acting as special financial and strategic business advisor. Mr. Samad is also a member of the Asian American Writers Workshop in New York City, and has worked extensively int eh service of several nonprofits entrusted with meeting the social, financial and healthcare needs of people with disabilities.

Dr. Jonathan Wiesen is a pulmonary and critical care physician, teacher, researcher and medical technology pioneer with a passion for clinical medicine and telehealth innovation.

Graduating from the Albert Einstein College of Medicine with distinction in research, he completed his training in internal medicine as well as pulmonary and critical care at the Cleveland Clinic - earning an advanced teaching degree and several teaching and research awards.

As founder and chief medical officer of MediOrbis, he leads the development of ground-breaking clinical programs for monitoring and managing chronic medical conditions and providing integrated medical specialty services. He has also developed a global network of top physicians to deliver the company’s telemedicine services worldwide.

Currently, Dr. Wiesen is a pulmonary specialist at Ben Gurion University’s Soroka Medical Center, where he directs the Cardio-Pulmonary Exercise Program.  He plays an active role as an advisor to a number of medical technology companies, and serves on the board of several companies including the most active venture capital firm in Israel, specializing in clinical assessment and due diligence. 

TLI Advisors

TLI Advisors are a diverse group of talented and experienced individuals who provide ongoing advice and support as an Advisory Board to the Board of Directors.

Click to read more.

Mr. Dea Belazi leads AscellaHealth, which provides pharmacy benefit manager services to nearly 3 million people in the commercial, Medicaid and Medicare markets.

He operates the independent consultancy, AlchemiPharma, whose clients include pharmaceutical manufacturers and health plans. The consultancy focuses on many areas including pharmacy benefit strategies, formulary management, contracting, business development strategies, and health economics and outcomes research. Belazi is also the principal and owner of CrowdHealth, a social networking site for consumers to share healthcare experiences. Belazi founded and leads the business development of two other Pharmacy Benefit Managers, PerformRx and FutureScripts, which was acquired in September 2010 by Catamaran. Mr. Belazi holds a Masters of Public Health at Johns Hopkins University.

Ms. Lynly Boor is an executive-level valued advisor with more than 25 years of experience in strategic communications, public and government affairs, partnership-building and business development.

She is committed to advancing the needs of our nation’s service members, veterans and military families. Ms. Boor served as Head of External Relations at the United Service Organizations (USO) where she led USO’s relationships with Congress, the White House, Executive Branch agencies and key stakeholder groups. She spearheaded successful advocacy efforts and built collaborative relationships with the entertainment industry, partner organizations and targeted external constituencies to generate public awareness and ongoing engagement in support of USO goals and bottom-line objectives. These include securing over $160M in appropriated funds and corporate / individual support; building one of the largest and most engaged Caucuses on Capitol Hill with over 225 Members of Congress; partnering with White House on more collaborative engagement and military support events than any other non-profit within the space. Throughout her career, she is committed to achieving measurable outcomes and drive business forward in the public and private sectors. She received a B.A. in communications from the University of Maryland.

Dr. John M. Cho is a retired US Army Brigadier General with over 20 years of senior executive experience in healthcare operations, management, and administration and in leading the planning and direction of complex health management organizations — from clinics to large healthcare systems.

As the Deputy Chief of Staff, Support (G-1/4/6), he was the responsible General Officer (GO) for 200 senior corporate headquarters staff and all Army Medicine issues related to information management, information technology, cyber, clinical informatics, the new $4.5B DoD electronic health record (MHS Genesis, Army Functional GO Champion), military and civilian human resources, talent management and medical logistics for the US Army Medical Command- an $11.5B healthcare system with 65,000 personnel serving 1.5M beneficiaries worldwide. He has a proven track record of leading change, achieving value for large organizations through creative and effective strategic problem solving, and effective coaching and mentoring leading to former subordinates serving as the CEO of hospitals and large clinics. Dr. Cho is a Certified Physician Executive (CPE) of the American Association for Physician Leadership since 2011, Board Certified in Cardiothoracic and General Surgery, American Board of Surgery, in 1998 and 1995 respectively and a Fellow American College of Surgeons (FACS) in 2000. He was recently selected by the Board of Directors for AMSUS, The Society of Federal Health Professionals, as its Executive Director. Organized in 1891 and chartered by Congress in 1903, AMSUS is a 501(c)(3) non-profit membership-based organization, the voice for federal health professionals and advocate for interagency healthcare collaboration among the Department of Defense, Veterans Affairs, and Health and Human Services.

Mr. Robert Clerman has more than 30 years of experience at the intersection of public policy, science and technology. Mr. Clerman’s experience focuses on formulating innovative solutions for clients facing complex technical and management challenges in fields like national security, environmental sustainability and healthcare. 

His interests include homeland security, health, biological defense, public health preparedness, and critical infrastructure protection. He works with government agencies and businesses on strategic initiatives that drive innovation and business growth, including launching new services, winning contract awards, diversifying into new markets, assessing technology, and develop branding, account development, and capture strategies. He also serves on the Boards of TEAM Integrated Engineering and Systems Development and Analysis, Inc. (SDA). Mr. Clerman served as the Corporate Vice President for Mission Development at Noblis, where he provided branding, program management and business development leadership. At Noblis and its predecessor organizations, Mitretek Systems and MITRE, he worked with teams from across the corporation and other organizations to conduct studies, develop new business, disseminate and evolve the corporation’s strategic plan, and communicate brand value to employees, customers and other stakeholders.

Dr. Charles Bruce Green was the 20th Air Force Surgeon General and the functional manager of the U.S. Air Force Medical Service.

He is an expert in anything related to the Military Health System, veterans’ health, medical disaster response, air evacuation, patient centered medical home, connected health, and health analytics. Dr. Green is a managing director with Deloitte Consulting LLP, serving as chief medical officer for Deloitte’s Federal Health practice.

Dr. Green is an advisor to Deloitte’s federal and commercial health clients and a thought leader in clinical public health leadership and preparedness. He serves as a consultant to health industry and corporate boards, improving private sector and government care by strategically planning sustainable models of care. He has a MD and a MPH from the Harvard School of Public Health and is board certified in Aerospace Medicine.

Dr. Sidney Levitsky serves as a Senior Vice Chairman of Department of Surgery at Beth Israel Deaconess Medical Center, Boston, a major teaching hospital of Harvard Medical School.

Dr. Levitsky is the David W. and David Cheever Professor of Surgery at Harvard Medical School and Director, Cardiothoracic Surgery for the CARE GROUP in Boston. He served as President of the Society of Thoracic Surgeons (2005 to 2006) and has held faculty positions at Yale University School of Medicine, the National Heart Institute, the University of Illinois College of Medicine, Cook County Graduate School and Harvard Medical School. He has been a Member of Scientific Advisory Board at CellAegis Devices Inc. since August 2012. He serves as a Member of Board of Trustees at Harvard Clinical Research Institute, Inc. He has authored over 450 journal articles and publications with a focus on intraoperative myocardial protection and ischemia/reperfusion injury of the heart. Dr. Levitsky received his M.D. degree from Albert Einstein College of Medicine and is board certified in surgery and thoracic surgery.